Frontiers in Pharmacology (Oct 2024)
Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder
Abstract
No abstracts available.Keywords